Cost-effectiveness of differentiated care models that incorporate economic strengthening for HIV antiretroviral therapy adherence: a systematic review.
Annie LiangMarta G Wilson-BarthesOmar GalárragaPublished in: Cost effectiveness and resource allocation : C/E (2024)
All economic evaluations in this review found that including economic strengthening as part of comprehensive differentiated service delivery was cost-effective at a willingness to pay threshold of at least 2 times the national per capita gross domestic product. Two of the three studies in this review focused on adolescents, suggesting that these types of care models may be especially cost-effective for youth entering adulthood. All studies were from the provider perspective, indicating that additional evidence is needed to inform the potential cost-savings of DSD and economic strengthening interventions to patients and society. Randomized trials testing the effectiveness of DSD models that integrate economic strengthening should place greater emphasis on costing these types of programs to inform the potential for bringing these types of multilevel interventions to scale.
Keyphrases
- antiretroviral therapy
- healthcare
- physical activity
- hiv infected
- quality improvement
- young adults
- human immunodeficiency virus
- hiv positive
- end stage renal disease
- mental health
- palliative care
- hiv aids
- primary care
- randomized controlled trial
- hiv infected patients
- life cycle
- newly diagnosed
- chronic kidney disease
- type diabetes
- ejection fraction
- public health
- peritoneal dialysis
- hepatitis c virus
- metabolic syndrome
- human health
- case control
- risk assessment
- health insurance
- men who have sex with men
- adipose tissue
- insulin resistance
- patient reported
- glycemic control